Innovative Research Development vs Ebitda Analysis

002173 Stock

8.28 0.04 0.48%

Innovative Medical financial indicator trend analysis is infinitely more than just investigating Innovative Medical recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Innovative Medical is a good investment. Please check the relationship between Innovative Medical Research Development and its Ebitda accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Innovative Medical Management. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Research Development vs Ebitda

Research Development vs Ebitda Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Innovative Medical Research Development account and Ebitda. At this time, the significance of the direction appears to have no relationship.

The correlation between Innovative Medical's Research Development and Ebitda is 0.08. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Ebitda in the same time period over historical financial statements of Innovative Medical Management, assuming nothing else is changed. The correlation between historical values of Innovative Medical's Research Development and Ebitda is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Innovative Medical Management are associated (or correlated) with its Ebitda. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebitda has no effect on the direction of Research Development i.e., Innovative Medical's Research Development and Ebitda go up and down completely randomly.

Correlation Coefficient

0.08

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Research Development

Ebitda

Most indicators from Innovative Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Innovative Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Innovative Medical Management. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

As of February 3, 2025, Selling General Administrative is expected to decline to about 40.6 M. In addition to that, Discontinued Operations is expected to decline to about (9.9 M)

	2022	2024	2025 (projected)
Other Operating Expenses	3.7M	3.3M	4.8M
Gross Profit	30.6M	83.0M	120.8M

Other Operating Expenses Gross Profit

Innovative Medical fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Retained Earnings	Accounts Payable	Cash	Net Receivables	Inventory	Other Current Assets	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Other Assets	Long Term Debt	Other Liab	Treasury Stock	Net Tangible Assets	Other Stockholder Equity	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Total Current Assets	Short Term Debt	Non Current Assets Total
Total Assets		0.01	0.54	0.99	-0.02	0.41	0.78	0.71	-0.08	0.38	0.74	0.77	0.76	0.66	0.86	0.07	0.52	0.03	0.89	0.84	0.37	0.84	0.83	0.78	0.75	-0.05
Other Current Liab	0.01		0.45	-0.06	0.41	-0.46	-0.36	0.0	0.52	0.0	0.42	-0.28	-0.26	-0.36	-0.33	0.12	0.0	-0.45	-0.25	-0.27	-0.56	-0.28	-0.01	0.22	-0.29	0.37
Total Current Liabilities	0.54	0.45		0.44	0.51	-0.21	0.31	0.47	0.72	0.07	0.94	0.16	0.2	-0.05	0.27	0.26	-0.16	-0.1	0.22	0.14	-0.25	0.14	0.6	0.73	-0.01	0.41
Total Stockholder Equity	0.99	-0.06	0.44		-0.09	0.47	0.79	0.7	-0.2	0.4	0.65	0.8	0.79	0.71	0.88	0.02	0.57	0.06	0.92	0.88	0.43	0.88	0.81	0.74	0.8	-0.11
Retained Earnings	-0.02	0.41	0.51	-0.09		-0.89	-0.26	0.43	0.78	0.33	0.36	-0.6	-0.59	-0.73	-0.3	0.62	-0.73	-0.42	-0.42	-0.54	-0.83	-0.55	0.4	0.5	-0.65	0.98
Accounts Payable	0.41	-0.46	-0.21	0.47	-0.89		0.57	-0.03	-0.74	-0.09	-0.03	0.87	0.88	0.95	0.66	-0.52	0.77	0.54	0.75	0.81	0.95	0.81	0.01	-0.14	0.86	-0.9
Cash	0.78	-0.36	0.31	0.79	-0.26	0.57		0.42	-0.21	0.08	0.51	0.79	0.77	0.7	0.85	-0.02	0.46	0.23	0.83	0.83	0.5	0.83	0.52	0.55	0.69	-0.3
Net Receivables	0.71	0.0	0.47	0.7	0.43	-0.03	0.42		0.09	0.75	0.56	0.31	0.37	0.25	0.63	0.45	-0.01	-0.06	0.51	0.36	0.04	0.36	0.84	0.71	0.31	0.43
Inventory	-0.08	0.52	0.72	-0.2	0.78	-0.74	-0.21	0.09		-0.17	0.55	-0.53	-0.48	-0.69	-0.39	0.51	-0.63	-0.33	-0.47	-0.51	-0.76	-0.52	0.14	0.36	-0.65	0.69
Other Current Assets	0.38	0.0	0.07	0.4	0.33	-0.09	0.08	0.75	-0.17		0.14	0.11	0.13	0.12	0.42	0.23	-0.07	-0.13	0.26	0.15	0.07	0.14	0.63	0.31	0.18	0.43
Total Liab	0.74	0.42	0.94	0.65	0.36	-0.03	0.51	0.56	0.55	0.14		0.36	0.41	0.18	0.48	0.28	0.11	-0.11	0.45	0.39	-0.08	0.38	0.67	0.81	0.22	0.27
Intangible Assets	0.77	-0.28	0.16	0.8	-0.6	0.87	0.79	0.31	-0.53	0.11	0.36		0.96	0.96	0.87	-0.44	0.77	0.38	0.96	0.96	0.81	0.96	0.42	0.33	0.94	-0.62
Common Stock	0.76	-0.26	0.2	0.79	-0.59	0.88	0.77	0.37	-0.48	0.13	0.41	0.96		0.96	0.88	-0.26	0.75	0.41	0.94	0.93	0.83	0.94	0.4	0.29	0.92	-0.63
Property Plant Equipment	0.66	-0.36	-0.05	0.71	-0.73	0.95	0.7	0.25	-0.69	0.12	0.18	0.96	0.96		0.83	-0.39	0.82	0.42	0.92	0.93	0.9	0.93	0.28	0.14	0.96	-0.73
Other Assets	0.86	-0.33	0.27	0.88	-0.3	0.66	0.85	0.63	-0.39	0.42	0.48	0.87	0.88	0.83		-0.1	0.54	0.28	0.92	0.88	0.7	0.88	0.66	0.49	0.83	-0.29
Long Term Debt	0.07	0.12	0.26	0.02	0.62	-0.52	-0.02	0.45	0.51	0.23	0.28	-0.44	-0.26	-0.39	-0.1		-0.41	-0.29	-0.22	-0.27	-0.49	-0.27	0.26	0.33	-0.37	0.6
Other Liab	0.52	0.0	-0.16	0.57	-0.73	0.77	0.46	-0.01	-0.63	-0.07	0.11	0.77	0.75	0.82	0.54	-0.41		0.15	0.72	0.81	0.67	0.81	0.03	0.05	0.85	-0.72
Treasury Stock	0.03	-0.45	-0.1	0.06	-0.42	0.54	0.23	-0.06	-0.33	-0.13	-0.11	0.38	0.41	0.42	0.28	-0.29	0.15		0.28	0.28	0.56	0.3	-0.08	-0.25	0.31	-0.52
Net Tangible Assets	0.89	-0.25	0.22	0.92	-0.42	0.75	0.83	0.51	-0.47	0.26	0.45	0.96	0.94	0.92	0.92	-0.22	0.72	0.28		0.97	0.71	0.97	0.61	0.52	0.93	-0.44
Other Stockholder Equity	0.84	-0.27	0.14	0.88	-0.54	0.81	0.83	0.36	-0.51	0.15	0.39	0.96	0.93	0.93	0.88	-0.27	0.81	0.28	0.97		0.75	1.0	0.49	0.4	0.96	-0.55
Deferred Long Term Liab	0.37	-0.56	-0.25	0.43	-0.83	0.95	0.5	0.04	-0.76	0.07	-0.08	0.81	0.83	0.9	0.7	-0.49	0.67	0.56	0.71	0.75		0.76	0.08	-0.18	0.82	-0.8
Long Term Investments	0.84	-0.28	0.14	0.88	-0.55	0.81	0.83	0.36	-0.52	0.14	0.38	0.96	0.94	0.93	0.88	-0.27	0.81	0.3	0.97	1.0	0.76		0.48	0.39	0.96	-0.56
Short Long Term Debt	0.83	-0.01	0.6	0.81	0.4	0.01	0.52	0.84	0.14	0.63	0.67	0.42	0.4	0.28	0.66	0.26	0.03	-0.08	0.61	0.49	0.08	0.48		0.86	0.38	0.4
Total Current Assets	0.78	0.22	0.73	0.74	0.5	-0.14	0.55	0.71	0.36	0.31	0.81	0.33	0.29	0.14	0.49	0.33	0.05	-0.25	0.52	0.4	-0.18	0.39	0.86		0.22	0.45
Short Term Debt	0.75	-0.29	-0.01	0.8	-0.65	0.86	0.69	0.31	-0.65	0.18	0.22	0.94	0.92	0.96	0.83	-0.37	0.85	0.31	0.93	0.96	0.82	0.96	0.38	0.22		-0.64
Non Current Assets Total	-0.05	0.37	0.41	-0.11	0.98	-0.9	-0.3	0.43	0.69	0.43	0.27	-0.62	-0.63	-0.73	-0.29	0.6	-0.72	-0.52	-0.44	-0.55	-0.8	-0.56	0.4	0.45	-0.64

Click cells to compare fundamentals

Innovative Medical Account Relationship Matchups

Innovative Medical fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	2.7B	2.6B	2.3B	2.3B	2.6B	1.9B
Other Current Liab	113.8M	77.2M	6K	47.7K	54.9K	52.1K
Total Current Liabilities	358.4M	346.0M	322.4M	325.4M	374.2M	442.5M
Total Stockholder Equity	2.1B	2.0B	1.9B	1.9B	2.2B	1.4B
Retained Earnings	(1.1B)	(1.2B)	(1.3B)	(1.3B)	(1.2B)	(1.1B)
Accounts Payable	180.5M	183.4M	210.1M	208.1M	239.3M	251.3M
Cash	346.3M	225.7M	658.5M	563.1M	647.5M	679.9M
Net Receivables	72.9M	83.4M	51.6M	102.8M	118.3M	136.4M
Inventory	34.5M	43.0M	49.3M	41.8M	37.6M	35.7M
Other Current Assets	20.2M	7.8M	3.0M	1.1M	1.3M	1.2M
Total Liab	533.1M	565.3M	434.4M	410.4M	471.9M	525.7M
Intangible Assets	128.7M	125.2M	121.8M	129.6M	149.0M	156.4M
Property Plant Equipment	1.4B	1.4B	1.4B	1.4B	1.6B	1.7B
Other Assets	121.5M	89.0M	38.5M	73.5M	84.5M	88.8M
Other Liab	120.9M	165.7M	185.4M	90.5M	104.1M	54.8M
Net Tangible Assets	2.5B	2.2B	2.0B	1.9B	2.1B	2.2B
Deferred Long Term Liab	36.2M	28.9M	22.6M	52.6M	60.4M	63.5M
Total Current Assets	1.1B	940.0M	771.6M	733.1M	659.8M	1.1B
Non Current Assets Total	1.6B	1.6B	1.6B	1.5B	1.4B	1.5B
Non Currrent Assets Other	7.5M	6.7M	1.6M	1.8M	1.6M	1.5M
Good Will	1.0B	127.0M	0.0	986.7K	888.1K	843.7K
Non Current Liabilities Total	174.7M	219.3M	112.0M	85.0M	76.5M	129.2M
Non Current Liabilities Other	113.4M	130.4M	39.2M	16.0M	18.4M	17.5M
Short Term Investments	61.4M	593.5M	574.0M	20.1M	18.1M	17.2M
Net Invested Capital	2.2B	2.0B	1.9B	1.9B	1.7B	2.1B
Net Working Capital	761.6M	594.1M	449.3M	407.6M	366.9M	669.6M
Property Plant And Equipment Net	1.4B	1.4B	1.4B	1.3B	1.2B	1.1B
Property Plant And Equipment Gross	2.0B	2.1B	1.4B	2.1B	1.9B	1.5B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

EBR	Centrais Electricas Brasileiras
HE	Hawaiian Electric Industries
VFC	VF Corporation

Other Information on Investing in Innovative Stock

Balance Sheet is a snapshot of the financial position of Innovative Medical at a specified time, usually calculated after every quarter, six months, or one year. Innovative Medical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Innovative Medical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Innovative currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Innovative Research Development vs Ebitda Analysis

Research Development vs Ebitda

Research Development vs Ebitda Correlation Analysis

Correlation Coefficient

Research Development

Ebitda

Innovative Medical fundamental ratios Correlations

Innovative Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Innovative Medical fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in Innovative Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Long Term Investments	+ 1.0	Other Stockholder Equity
Total Stockholder Equity	+ 0.99	Total Assets
Non Current Assets Total	+ 0.98	Retained Earnings
Other Stockholder Equity	+ 0.97	Net Tangible Assets
Long Term Investments	+ 0.97	Net Tangible Assets
Common Stock	+ 0.96	Intangible Assets

Non Current Assets Total	- 0.9	Accounts Payable
Accounts Payable	- 0.89	Retained Earnings
Deferred Long Term Liab	- 0.83	Retained Earnings
Non Current Assets Total	- 0.8	Deferred Long Term Liab
Deferred Long Term Liab	- 0.76	Inventory
Inventory	- 0.74	Accounts Payable